The antiplatelet activity of Geiji-Bokryung-Hwan, Korean traditional formulation, is mediated through inhibition of phospholipase C and inhibition of TxB2 synthetase activity

International Immunopharmacology

Volumn 3, Issue 7, 2003, Pages 971-978

  Park, Won Hwan ^a,b   Kim, Kyoung Sook ^a,b   Kim, Kyung Ho ^a,b   Kim, Dong Soo ^c   Kim, Cheorl Ho ^a,b  

^a Dongguk University   (South Korea)

^b Ministry of Science and Technology   (South Korea)

^c Kyungsung University   (South Korea)

Author keywords

Arachidonic acid (AA); Atherosclerosis; Geiji Bokryung Hwan (GBH); Korean herbal medicine; Nitric oxide (NO); Phosphoinositide; Phospholipase C; Thromboxane synthetase; 3H Inositol monophosphate; 3H Myoinositol

Indexed keywords

ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; CALCIUM ION; COLLAGEN; GEIJI BOKRYUNG HWAN; INOSITOL PHOSPHATE; NITRATE; NITRIC OXIDE; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; THROMBOXANE A2; THROMBOXANE B2; THROMBOXANE SYNTHASE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM MOBILIZATION; CELL SUSPENSION; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG FORMULATION; ENZYME ACTIVITY; ENZYME INHIBITION; HERBAL MEDICINE; HUMAN; HUMAN CELL; MICROSOME; NORMAL HUMAN; PRIORITY JOURNAL; SOUTH KOREA; STATISTICAL SIGNIFICANCE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0037505441     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00095-X     Document Type: Article

References (25)

1. Li SC, Pen-Tsao Kang Mu. Republished by National Research Institute of Chinese Medicine, Taipei, 1976, 32, 1064, 1596.
2. Sugiyama K., Muteki T., Kano T. The Japanese herbal medicine 'saiko-keishi-to' activates GABAA receptors of rat sensory neurons in culture. Neurosci. Lett. 216:1996;147-150.
3. Ishikawa T., Funahashi T., Kudo J. Effectiveness of the Kampo kami-shoyo-san (TJ-24) for tremor of antipsychotic-induced parkinsonism. Psychiatry Clin. Neurosci. 54:2000;579-684.
4. Jiangsu Medical College Encyclopedia of Chinese materia medica. 1977;1300 Shanghai Science and Technology Press, Singapore.
5. Chang H.M., But P.P.H. Pharmacology and Applications of Chinese Materials Medica. vol. I:1987;605 World Scientific Publishing, Singapore.
6. Kim J.G., Kim C.H., Park S.Y., Kim J.S., Choi J.Y., Kim C.H.et al. An experimental study on the effect of Geijibokryunghwan, Dangguijakyaksan and each constituent herb on inhibition of platelet aggregation. J. Kor. Inst. Ori. Med. Diagnost. 4:2000;71-84.
7. Lee S.K., Kim J.G., Kim C.H., Park S.Y., Kim J.S., Choi J.Y.et al. Effect of the Geijibokryunghwan on human hepatocarcinoma cells. J. Kor. Inst. Ori. Med. Diagnost. 2003;. [in press].
8. Kim B.J., Kim Y.K., Park W.H., Ko J.H., Lee Y.C., Kim C.H. A water-extract of the Korean traditional formulation, Geiji-Bokryung-Hwan (GBH) reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbits. Int. Immunopharm. 2003;. [in press].
9. Lee S.K. Effect of the Geijibokryunghwan on human hepatocarcinoma cells. A thesis of degree of master, Dongguk Univ. Graduate School, Kyungju, Korea, 2001.
10. Huang T.F., Sheu J.R., Teng C.M. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom. Biochem. J. 277:1991;351-357.
11. 3H]arachidonic from human platelets stimulated by thrombin or collagen. Thromb. Haemost. 72:1994;634-642.
12. Neylon C.B., Summers R.J. Stimulation of 1-adrenoceptors in rat kidney mediates increased inositol phospholipid hydrolysis. Br. J. Pharmacol. 91:1987;363-376.
13. Lowry D.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
14. Needleman P., Raz A., Ferrendelli J.A., Minkes M. Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets. Proc. Natl. Acad. Sci. U. S. A. 74:1977;1716-1720.
15. Lloret S., Moreno J.J. In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins. Biochem. Pharmacol. 44:1992;37-41.
16. Mollace V., Salvemini D., Anggard E., Vane J. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Br. J. Pharmacol. 104:1991;633-639.
17. Metha J.L., Chen L.Y., Kone B.C., Mehta J.F., Turner P. Identification of constitute and inducible forms of nitric oxide synthase in human platelets. J. Lab. Clin. Med. 125:1995;370-377.
18. Radomski M.W., Palmer R.M.J., Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92:1987;639-646.
19. Nozawa Y., Nakasgima S., Nagata K. Phospholipid-mediated signalling in receptor activation of human platelets. Biochim. Biophys. Acta. 1082:1991;219-238.
20. Broekman M.J., Ward J.W., Marcus A.J. Phospholipid metabolism in stimulated human platelets. Changes in phosphatidyl inositol, phosphatic acid and lysophospholipids. J. Clin. Invest. 66:1980;275-283.
21. Mene P., Dunn M.J. Prostaglandins and rat glomerular mesangial cell proliferation. Kidney Int. 37:1990;1256-1262.
22. Radomski M.W., Palmer R.M.J., Moncada S. Characterization of the L-arginine: nitric oxide pathway in human platelets. Br. J. Pharmacol. 101:1990;325-328.
23. Berridge M.J. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem. J. 212:1983;849-858.
24. Bell R.L., Kennerly D.A., Stanford N., Majerus P.W. Diglyceride lipase: a pathway for arachidonic acid release from human platelets. Proc. Natl. Acad. Sci. U. S. A. 76:1979;3241-3258.
25. Mckean M.L., Smith J.B., Silver W.J. Formation of lysophosphatidylcholine in human platelets in response to thrombin. J. Biol. Chem. 256:1981;1522-1524.